| Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information. |
| |
| Device | DEXCOM G4 PLATINUM CONTIUOUS GLUCOSE MONITORING SYSTEM, DEXCOM G5 MOBILE CONTINUOUS GLUCOSE MONITORING SYSTEM |
| Generic Name | Sensor, glucose, invasive |
| Applicant | Dexcom, Inc. 6340 Sequence Dr. San Diego, CA 92121 |
| PMA Number | P120005 |
| Supplement Number | S061 |
| Date Received | 04/03/2017 |
| Decision Date | 04/26/2017 |
| Withdrawal Date | 03/20/2026 |
| Product Codes |
MDS PQF |
| Advisory Committee |
Clinical Chemistry |
| Clinical Trials | NCT01514292
|
| Supplement Type | 30-Day Notice |
| Supplement Reason | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
| Recalls | CDRH Recalls |
Approval Order Statement Relocate storage and shipping activities for finished products for the Dexcom G4 Platinum Contiuous Glucose Monitoring Systemand the Dexcom G5 Mobile Continuous Glucose Monitoring System to a new warehouse facility. |
|
|